Our pipeline product candidates demonstrate our leadership in drug development for infection and inflammation where therapeutic areas with unmet medical needs. The proof is in our substantial pipeline and its potential to produce a positive impact to end users.

  • APC0101
  • APC0201
  • APC0301
  • APC0401